 |
市场调查报告书
商品编码
1672683
全球狼疮治疗市场按疾病类型、治疗类型、给药途径、分销管道和地区划分Lupus Therapeutic Market, By Disease Type, By Treatment Type, By Route of Administration, By Distribution Channel, By Geography |
||||||
价格
简介目录
2025 年全球狼疮治疗市场规模估计为 35.5 亿美元，预计到 2032 年将达到 65.3 亿美元，2025 年至 2032 年的复合年增长率为 9.1%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025 年市场规模 | 35.5亿美元 |
| 效能资料 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 9.10% | 2032 年价值预测 | 65.3亿美元 |
图。
由于全球红斑性狼疮盛行率不断上升，全球红斑狼疮治疗市场在过去几年一直稳定成长。狼疮是一种慢性自体免疫疾病，人体的免疫系统开始攻击自身的组织和器官。它通常影响育龄妇女，主要症状包括关节疼痛，皮疹，疲劳和器官发炎。据估计，大约有 150 万美国人和全世界至少 500 万人患有狼疮。政府和医疗保健组织对于狼疮早期诊断和治疗的认识不断提高，进一步推动了市场的成长。此外，在预测期内，持续进行的开发更安全、更有效的治疗方法的研究也将推动市场的成长。
市场动态：
全球狼疮治疗市场受到世界范围内狼疮患病率不断上升、狼疮宣传活动日益增多以及医疗保健支出不断增加的推动。根据美国狼疮基金会统计，美国每年报告的新患者约为 16,000 例。政府对狼疮药物研发活动的积极支持也推动了市场的成长。然而，治疗费用高昂以及器官特异性狼疮药物的短缺是预计在一定程度上抑制市场成长的主要因素。同时，正在进行的新型生物製药和个人化药物的临床试验预计将在未来几年为市场进入者提供丰厚的机会。
本研究的主要特点
- 本报告对全球狼疮治疗市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模和復合年增长率。
- 它还强调了各个领域的潜在收益成长机会，并说明了该市场的引人注目的投资提案矩阵。
- 它还提供了关于市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的主要考察。
- 全球狼疮治疗市场的主要企业简介是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的。
- 主要企业包括 Hikma Pharmaceuticals PLC、Dr. Reddy's Laboratories Ltd.、Amgen Inc.、Novartis AG、Sanofi、UCB SA、ImmuPharma PLC、Bayer AG、Merck &Co.、Aurinia Pharmaceuticals Inc.、Pfizer Inc.、Astrak-bacers Ltd. 工业 Ltd. 和 Boehringer Ingelheim International Gmbh。
- 本报告的见解将帮助负责人和公司经营团队就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
- 全球狼疮治疗市场迎合了该行业的各种相关人员，例如投资者、供应商、产品製造商、经销商、新进入者和金融分析师。
- 相关人员可以透过用于分析全球狼疮治疗市场的各种策略矩阵来促进他们的决策。
目录
第一章 调查目的与前提条件
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
- Coherent Opportunity Map（COM）
第三章市场动态、法规与趋势分析
- 市场动态
- 驱动程式
- 限制因素
- 机会
- 影响分析
- 流行病学
- 市场趋势
- 主要进展
- 监管情景
- 製造商收益
- 收购和合作场景
- 产品发布/核准
- 资金筹措和投资
- PEST分析
- 波特的分析
4. 全球狼疮治疗市场：COVID-19 疫情的影响
- 整体影响
- 政府倡议
- COVID-19 市场影响
5. 全球狼疮治疗市场按疾病类型划分（2020-2032 年）
- 全身性红斑性狼疮（SLE）
- 皮肤红斑狼疮
- 药物性红斑狼疮
- 新生儿狼疮
6. 全球狼疮治疗市场按治疗类型划分（2020-2032 年）
- 非类固醇消炎剂(NSAID)
- 生物製药
- 抗疟疾药
- 皮质类固醇
- 其他的
7. 全球狼疮治疗市场依给药途径划分（2020-2032 年）
- 口服
- 皮下
- 静脉
- 其他的
8. 全球狼疮治疗市场按分销管道划分（2020-2032 年）
- 院内药房
- 医疗用品商店
- 其他的
9. 全球狼疮治疗市场按地区划分（2020-2032 年）
- 北美洲
- 拉丁美洲
- 欧洲
- 亚太地区
- 中东
- 非洲
第十章 竞争格局
- 公司简介
- Hikma Pharmaceuticals PLC
- Dr. Reddy's Laboratories Ltd.
- Amgen Inc.
- Novartis AG
- Sanofi
- UCB SA
- ImmuPharma PLC
- Bayer AG
- Merck &Co., Inc.
- Aurinia Pharmaceuticals Inc.
- Pfizer Inc.
- AstraZeneca
- F.Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International Gmbh
第 11 章 分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map（COM）
第 12 章参考文献与调查方法
- 参考
- 调查方法
简介目录
Product Code: CMI4958
Global Lupus Therapeutic Market is estimated to be valued at USD 3.55 Bn in 2025 and is expected to reach USD 6.53 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.1% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.55 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 9.10% | 2032 Value Projection: | USD 6.53 Bn |
Figure. Lupus Therapeutic Market Share (%), By Region 2025
The global lupus therapeutic market has been witnessing steady growth over the past few years owing to the rising prevalence of lupus disease globally. Lupus is a chronic autoimmune disorder where the immune system of the body starts attacking its own tissues and organs. It commonly affects women in their childbearing years and major symptoms include joint pain, rashes, fatigue, and organ inflammation. According to estimates, about 1.5 million Americans and at least 5 million people worldwide suffer from a form of lupus. Growing awareness initiatives by government and healthcare organizations regarding early diagnosis and treatment of lupus has further boosted the market growth. Moreover, ongoing research into developing safer and more effective therapeutic drugs will continue driving the market growth during the forecast period.
Market Dynamics:
The global lupus therapeutic market is driven by the growing prevalence of lupus globally, rising awareness initiatives regarding the disease, and increasing healthcare expenditure. As per the Lupus Foundation of America, around 16,000 new cases are reported in the U.S. every year. Favorable government support for research and development activities focused on lupus therapeutics is also propelling the market growth. However, high treatment cost and lack of drugs for organ-specific lupus are some of the key factors expected to restrain the market growth to a certain extent. On the other hand, ongoing clinical trials for novel biologic drugs and personalized medicine offer lucrative opportunities for market players in the coming years.
Key Features of the Study:
- This report provides an in-depth analysis of the global lupus therapeutic market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global lupus therapeutic market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this includes Hikma Pharmaceuticals PLC, Dr. Reddy's Laboratories Ltd., Amgen Inc., Novartis AG, Sanofi, UCB S.A., ImmuPharma PLC, Bayer AG, Merck & Co., Inc., Aurinia Pharmaceuticals Inc., Pfizer Inc., AstraZeneca, F.Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, Teva Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited, and Boehringer Ingelheim International Gmbh.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- Global lupus therapeutic market caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global lupus therapeutic market.
Detailed Segmentation-
- By Disease Type:
- Systemic Lupus Erythematosus (SLE)
- Cutaneous Lupus Erythematosus
- Drug-Induced Lupus Erythematosus
- Neonatal Lupus
- By Treatment Type:
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
- Biologics
- Antimalarial Drugs
- Corticosteroids
- Others
- By Route of Administration:
- Oral
- Subcutaneous
- Intravenous
- Others
- By Distribution Channel:
- Hospital Pharmacies
- Medical Stores
- Others
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
- Company Profiles:
- Hikma Pharmaceuticals PLC
- Reddy's Laboratories Ltd.
- Amgen Inc.
- Novartis AG
- Sanofi
- UCB S.A.
- ImmuPharma PLC
- Bayer AG
- Merck & Co., Inc.
- Aurinia Pharmaceuticals Inc.
- Pfizer Inc.
- AstraZeneca
- Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International Gmbh
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Disease Type
- Market Snapshot, By Treatment Type
- Market Snapshot, By Route of Administration
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Epidemiology
- Market Trends
- Key Developments
- Regulatory Scenario
- Manufacturer Revenue
- Acquisitions and Partnerships Scenario
- Product Launches/Approvals
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Lupus Therapeutic Market - Impact of Coronavirus (COVID-19) Pandemic
- Overall Impact
- Government Initiatives
- COVID-19 Impact on the Market
5. Global Lupus Therapeutic Market, By Disease Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Systemic Lupus Erythematosus (SLE)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Cutaneous Lupus Erythematosus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Drug-Induced Lupus Erythematosus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Neonatal Lupus
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Lupus Therapeutic Market, By Treatment Type, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Non-Steroidal Anti-Inflammatory Drugs (NSAIDS)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Biologics
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Antimalarial Drugs
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Corticosteroids
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Lupus Therapeutic Market, By Route of Administration, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Oral
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Subcutaneous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Intravenous
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Lupus Therapeutic Market, By Distribution Channel, 2020 - 2032, (USD Bn)
- Overview
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2020 - 2032
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Medical Stores
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Lupus Therapeutic Market, By Region, 2020 - 2032, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2020-2032
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Disease Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2032, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- North Africa
- Central Africa
- South Africa
10. Competitive Landscape
- Company Profiles
- Hikma Pharmaceuticals PLC
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Dr. Reddy's Laboratories Ltd.
- Amgen Inc.
- Novartis AG
- Sanofi
- UCB S.A.
- ImmuPharma PLC
- Bayer AG
- Merck & Co., Inc.
- Aurinia Pharmaceuticals Inc.
- Pfizer Inc.
- AstraZeneca
- F.Hoffmann-La Roche Ltd
- Bristol-Myers Squibb Company
- Teva Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Company Limited
- Boehringer Ingelheim International Gmbh
- Hikma Pharmaceuticals PLC
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us and Sales Contact
